3D Designed Defocus Lenses on Myopia Control in Children and Adolescents
Sponsored by Shanghai Eye Disease Prevention and Treatment Center
About this trial
Last updated 6 months ago
Study ID
QX-2025-A-012
Status
Enrolling by invitation
Type
Interventional
Phase
N/A
Placebo
No
Accepting
6 to 14 Years
All Sexes
Trial Timing
Started 9 months ago
What is this trial about?
This study aims to evaluate the effectiveness of lenses with 3D Designed Defocus in controlling the progression of myopia in children and adolescents, and to explore the feasibility of effective design, and apply personalized frame lenses for myopia prevention and control.
What are the participation requirements?
Inclusion Criteria
Age: 6-14 years old; After using 1% cyclohexanone hydrochloride eye drops (Saifeijie) for ciliary muscle paralysis, binocular spherical power were within -0.40D~-4.00D, binocular cylinder power ≤ 1.50D, the anisometropia is ≤ 1.50D, the progression of myopia in the past year is greater than 0.5D, the best corrected far vision is at least 4.8, and the near vision is at least 5.0; Within 3 months, the myopia prevention and control methods such as multifocal glasses, orthokeratology, defocusing flexible glasses, progressive glasses, atropine eye drops, red light and acupuncture and moxibustion treatment were not used; The subject has a willingness to receive treatment and an informed consent form is signed by their legal guardian.
Exclusion Criteria
-